Immuno-regulated common markers but different network signatures in two associated cancers: evidences from epigenetic treatment

Abstract

Our evidence is relevant to therapeutic developments, indicating that preference should be assigned to the assessment of bio-entities in a connected environment rather than considering single entities alone.